Literature DB >> 14595029

Endogenous neosynthesis vs. cross-presentation of viral antigens for cytotoxic T cell priming.

Stefan Freigang1, Denise Egger, Kurt Bienz, Hans Hengartner, Rolf M Zinkernagel.   

Abstract

Induction of antiviral cytotoxic T lymphocytes (CTLs) has been proposed to require cross-presentation of viral antigens derived from infected extralymphatic host cells by antigen-presenting cells (APC). This postulated mechanism of cross-priming is thought to be essential for CTL responses against viruses that do not infect professional APC, e.g., because of absence of the specific virus receptor. Here, we show for the human pathogen poliovirus that naturally nonpermissive murine APC acquire viral RNA in vivo independently of the cellular virus receptor. Uptake of poliovirus or polioviral RNA initiated neosynthesis of viral antigen to an extent sufficient to prime CTLs in vivo, which were detectable 2-3 wk after infection. Our results do not only indicate that experiments studying cross-presentation and cross-priming by using potentially amplifiable or translatable materials need careful examination, but they also question the general biological importance of cross-presentation and cross-priming in antiviral CTL responses.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14595029      PMCID: PMC263839          DOI: 10.1073/pnas.1835685100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

Review 1.  Generating MHC class I ligands from viral gene products.

Authors:  J Yewdell; L C Antón; I Bacik; U Schubert; H L Snyder; J R Bennink
Journal:  Immunol Rev       Date:  1999-12       Impact factor: 12.988

Review 2.  Cross-presentation, dendritic cells, tolerance and immunity.

Authors:  W R Heath; F R Carbone
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

3.  MHC-I-restricted presentation of HIV-1 virion antigens without viral replication.

Authors:  F Buseyne; S Le Gall; C Boccaccio; J P Abastado; J D Lifson; L O Arthur; Y Rivière; J M Heard; O Schwartz
Journal:  Nat Med       Date:  2001-03       Impact factor: 53.440

4.  Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particles.

Authors:  Tazio Storni; Franziska Lechner; Iris Erdmann; Thomas Bächi; Andrea Jegerlehner; Tilman Dumrese; Thomas M Kündig; Christiane Ruedl; Martin F Bachmann
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

5.  Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells.

Authors:  A Rodriguez; A Regnault; M Kleijmeer; P Ricciardi-Castagnoli; S Amigorena
Journal:  Nat Cell Biol       Date:  1999-10       Impact factor: 28.824

Review 6.  On cross-priming of MHC class I-specific CTL: rule or exception?

Authors:  Rolf M Zinkernagel
Journal:  Eur J Immunol       Date:  2002-09       Impact factor: 5.532

7.  Isolation and characterization of 'dense particles' from poliovirus-infected HeLa cells.

Authors:  U Yamaguchi-Koll; K J Wiegers; R Drzeniek
Journal:  J Gen Virol       Date:  1975-03       Impact factor: 3.891

8.  Cross-presentation by dendritic cells of tumor antigen expressed in apoptotic recombinant canarypox virus-infected dendritic cells.

Authors:  I Motta; F André; A Lim; J Tartaglia; W I Cox; L Zitvogel; E Angevin; P Kourilsky
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

9.  Is the 135S poliovirus particle an intermediate during cell entry?

Authors:  Y Huang; J M Hogle; M Chow
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

10.  Poliovirus pathogenesis in a new poliovirus receptor transgenic mouse model: age-dependent paralysis and a mucosal route of infection.

Authors:  Shane Crotty; Laura Hix; Luis J Sigal; Raul Andino
Journal:  J Gen Virol       Date:  2002-07       Impact factor: 3.891

View more
  13 in total

Review 1.  Cross-presentation: dendritic cells and macrophages bite off more than they can chew!

Authors:  Sven Brode; Paul A Macary
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

Review 2.  Pathways for antigen cross presentation.

Authors:  Pierre Guermonprez; Sebastian Amigorena
Journal:  Springer Semin Immunopathol       Date:  2004-12-03

3.  Immunogenicity of cytopathic and noncytopathic viral vectors.

Authors:  Gabriela Plesa; Philip M McKenna; Matthias J Schnell; Laurence C Eisenlohr
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

4.  Cellular uptake followed by class I MHC presentation of some exogenous peptides contributes to T cell stimulatory capacity.

Authors:  Susan E Brophy; Lindsay L Jones; Phillip D Holler; David M Kranz
Journal:  Mol Immunol       Date:  2006-12-12       Impact factor: 4.407

5.  Contrasting effects of human, canine, and hybrid adenovirus vectors on the phenotypical and functional maturation of human dendritic cells: implications for clinical efficacy.

Authors:  Matthieu Perreau; Franck Mennechet; Nicolas Serratrice; Joel N Glasgow; David T Curiel; Harald Wodrich; Eric J Kremer
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

6.  Cross-presentation of a spread-defective MCMV is sufficient to prime the majority of virus-specific CD8+ T cells.

Authors:  Christopher M Snyder; Jane E Allan; Elizabeth L Bonnett; Carmen M Doom; Ann B Hill
Journal:  PLoS One       Date:  2010-03-12       Impact factor: 3.240

Review 7.  Bridging innate and adaptive antitumor immunity targeting glycans.

Authors:  Anastas Pashov; Bejatolah Monzavi-Karbassi; Gajendra P S Raghava; Thomas Kieber-Emmons
Journal:  J Biomed Biotechnol       Date:  2010-06-15

8.  Selectively reduced intracellular proliferation of Salmonella enterica serovar typhimurium within APCs limits antigen presentation and development of a rapid CD8 T cell response.

Authors:  Homam Albaghdadi; Nirmal Robinson; Brett Finlay; Lakshmi Krishnan; Subash Sad
Journal:  J Immunol       Date:  2009-08-19       Impact factor: 5.422

Review 9.  Mechanisms of lymphatic system-specific viral replication and its potential role in autoimmune disease.

Authors:  S-K Friedrich; P A Lang; J Friebus-Kardash; V Duhan; J Bezgovsek; K S Lang
Journal:  Clin Exp Immunol       Date:  2019-01       Impact factor: 4.330

10.  Enumeration and functional evaluation of virus-specific CD4+ and CD8+ T cells in lymphoid and peripheral sites of coxsackievirus B3 infection.

Authors:  Christopher C Kemball; Stephanie Harkins; J Lindsay Whitton
Journal:  J Virol       Date:  2008-02-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.